Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

3.070 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
News headline image
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining ↗
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
News headline image
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul ↗
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
News headline image
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position
From MEI Pharma, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
MEI Pharma Reports Fiscal Year End 2024 Cash Position
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
From MEI Pharma, Inc.
Via Business Wire
News headline image
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
MEI Pharma to Consider Strategic Alternatives
From MEI Pharma, Inc.
Via Business Wire
News headline image
7 Undervalued Biotech Stocks to Buy for Big-Time Returns ↗
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024 ↗
MEIP stock results show that MEI Pharma beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
News headline image
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
From MEI Pharma, Inc.
Via Business Wire
News headline image
5 Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
From MEI Pharma, Inc.
Via Business Wire
News headline image
A Look Into Healthcare Sector Value Stocks ↗
 
Via Benzinga
News headline image
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
From MEI Pharma, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock
From MEI Pharma, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.